» Articles » PMID: 6143758

Guanylate Cyclase from Bovine Lung. Evidence That Enzyme Activation by Phenylhydrazine is Mediated by Iron-phenyl Hemoprotein Complexes

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1984 May 10
PMID 6143758
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The mechanism of activation of soluble guanylate cyclase purified from bovine lung by phenylhydrazine is reported. Heme-deficient and heme-containing forms of guanylate cyclase were studied. Heme-deficient enzyme was activated 10-fold by NO but was not activated by phenylhydrazine. Catalase or methemoglobin enabled phenylhydrazine to activate guanylate cyclase 10-fold and enhanced activation by NO to over 100-fold. Heme-containing enzyme was activated only 3-fold by phenylhydrazine but over 100-fold by NO. Added hemoproteins enhanced enzyme activation by phenylhydrazine to 12-fold without enhancing activation by NO. Reducing or anaerobic conditions inhibited, whereas oxidants enhanced enzyme activation by phenylhydrazine plus catalase, and KCN had no effect. In contrast, enzyme activation by NO and NaN3 was inhibited by oxidants or KCN. NaN3 required native catalase, whereas phenylhydrazine also utilized heat-denatured catalase for enzyme activation. Thus, the mechanism of guanylate cyclase activation by phenylhydrazine differed from that by NO or NaN3. Guanylate cyclase activation by phenylhydrazine resulted from an O2-dependent reaction between phenylhydrazine and hemoproteins to generate stable iron-phenyl hemoprotein complexes. These complexes activated guanylate cyclase in the absence of O2, but lost activity after acidification, basification, or heating. Gel filtration of prereacted mixtures of [U-14C]phenylhydrazine plus hemoproteins resulted in co-chromatography of radioactivity, protein, and guanylate cyclase stimulating activity, and yielded a phenyl-hemoprotein binding stoichiometry of four under specified conditions (one phenyl/heme). [14C]Phenyl bound to heme-containing but not heme-deficient guanylate cyclase and binding correlated with enzyme activation. Moreover, reactions between enzyme and iron-[14C] phenyl hemoprotein complexes resulted in the exchange or transfer of iron-phenyl heme to guanylate cyclase and this correlated with enzyme activation.

Citing Articles

Nitric oxide as a key component in hormone-regulated processes.

Simontacchi M, Garcia-Mata C, Bartoli C, Santa-Maria G, Lamattina L Plant Cell Rep. 2013; 32(6):853-66.

PMID: 23584547 DOI: 10.1007/s00299-013-1434-1.


HBOC vasoactivity: interplay between nitric oxide scavenging and capacity to generate bioactive nitric oxide species.

Cabrales P, Friedman J Antioxid Redox Signal. 2012; 18(17):2284-97.

PMID: 23249305 PMC: 3638560. DOI: 10.1089/ars.2012.5099.


Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.

Ignarro L, Buga G, Wood K, Byrns R, Chaudhuri G Proc Natl Acad Sci U S A. 1987; 84(24):9265-9.

PMID: 2827174 PMC: 299734. DOI: 10.1073/pnas.84.24.9265.


Endothelium-derived nitric oxide: pharmacology and relationship to the actions of organic nitrate esters.

Ignarro L Pharm Res. 1989; 6(8):651-9.

PMID: 2510139 DOI: 10.1023/a:1015926119947.